C07D 505/18
Further acylated by radicals derived from carboxylic acids or by nitrogen or
Official title: further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
C07D505/18 (Further acylated by radicals derived from carboxylic acids or by nitrogen or) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C07D- Granted patents
- 4
- Published applications
- 5
- Assignees
- 4
- Inventors
- 17
- Latest grant
- 14 Jan 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
By publication year.
Subgroups
Granted patents
Recent patents
- Method for manufacturing 7alpha-alkoxyoxacephem intermediate compound14 Jan 2020US 10,533,019 B2Dongdo Co., Ltd.
- 2 substituted cephem compounds8 Jan 2019US 10,174,053 B2Glaxo Group Limited
- Cephalosporin having catechol group19 Jan 2016US 9,238,657 B2Shionogi & Co., Ltd.
- Cephem compound having catechol group29 Sep 2015US 9,145,425 B2Shionogi & Co., Ltd.
- Method for manufacturing 7alpha-alkoxyoxacephem intermediate compound14 Mar 2019US 2019/0077812 A1Dongdo Co., Ltd.
- 2 substituted cephem compounds5 Oct 2017US 2017/0281532 A1Glaxo Group Limited
- 2-substituted cephem compounds22 Oct 2015US 2015/0299223 A1Glaxo Group Limited
- Cephem compound having catechol group25 Apr 2013US 2013/0102583 A1Shionogi & Co., Ltd.
- Cephalosporin having catechol group4 Aug 2011US 2011/0190254 A1Shionogi & Co., Ltd.
Most cited
By later US patents